Renal Toxicity From Pemetrexed and Pembrolizumab in the Era of Combination Therapy in Patients With Metastatic Nonsquamous Cell NSCLC
Daphne W. Dumoulin, Sabine Visser, Robin Cornelissen, Teun van Gelder, Johan Vansteenkiste, Jan H. von der Thüsen, Joachim G.J.V. Aerts
Topics & Concepts
MedicinePemetrexedChemotherapyPembrolizumabOncologyInternal medicineAcute tubular necrosisAcute kidney injuryRenal functionImmunotherapyIntensive care medicineCancerCisplatinRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersChemotherapy-induced organ toxicity mitigation